Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

✍ Scribed by Ray-Coquard, I; Favier, L; Weber, B; Roemer-Becuwe, C; Bougnoux, P; Fabbro, M; Floquet, A; Joly, F; Plantade, A; Paraiso, D; Pujade-Lauraine, E

• Book ID: 120326081
• Publisher: Nature Publishing Group
• Year: 2013
• Tongue: English
• Weight: 271 KB
• Volume: 108
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/bjc.2013.183